Theron Pharmaceuticals Secures $409,099 New Round

  • Feed Type
  • Date
    8/6/2015
  • Company Name
    Theron Pharmaceuticals
  • Mailing Address
    365 San Aleso Avenue Sunnyvale, CA 94085 USA
  • Company Description
    Founded in 2008, Theron Pharmaceuticals is a privately held biotechnology company developing a best-in-class, long acting M3 muscarinic antagonist (LAMA) for the improved treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma.
  • Website
    http://www.theronpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $409,099
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy